💊 Oral Semaglutide Enters the Arena — The SOUL Trial

from Dr RR Baliga's "Got Knowledge Doc" Podkast · host MasterMedFacts LLC

The SOUL trial 🧪 showed that oral semaglutide 💊 significantly reduced major cardiovascular events ❤️ (MACE) in people with type 2 diabetes 🩸 and ASCVD/CKD 🚑. Over ~4 years, it cut heart attacks 💥, lowered HbA1c 📉, reduced weight ⚖️, and inflammation 🔥 — all with a once-daily pill 🕊️ and no rise in serious side effects.

Episode metadata supplied by the publisher feed · Published Apr 9, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

💊 Oral Semaglutide Enters the Arena — The SOUL Trial

0:00 3:11

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Dr RR Baliga's "Got Knowledge Doc" Podkast?

This episode is 3 minutes long.

When was this Dr RR Baliga's "Got Knowledge Doc" Podkast episode published?

This episode was published on April 9, 2025.

Can I download this Dr RR Baliga's "Got Knowledge Doc" Podkast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!